<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02530840</url>
  </required_header>
  <id_info>
    <org_study_id>0025-14-COM</org_study_id>
    <nct_id>NCT02530840</nct_id>
  </id_info>
  <brief_title>Improving Adherence and Commitment to Treatment in Diabetic Patients</brief_title>
  <official_title>Impact:Improving Adherence and Commitment to Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clalit Health Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clalit Health Services</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the IMPACT project, the investigators want to improve adherence and commitment to
      treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study the investigators use 3 interventions in diabetic patients and one control, to
      find what is the best intervention to improve adherence to healthy life style and medication
      therapy. the 3 intervention as followed: 1) meetings and follow-up by the medical team; 2)
      meetings and follow-up by trained peers; 3) system for sending SMS, operate according to
      algorithm.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2014</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diabetes Control as Expressed by the Change in HbA1c %</measure>
    <time_frame>0, 6, 12 &amp; 18 months</time_frame>
    <description>Participants will undergo HbA1c periodical lab test, the data needed for the trial will be extracted from electronic medical record</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>medical team</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>personal meetings and follow-up of un-balanced diabetic patients by trained medical team (nurse and doctor), which designed to promote adherence to healthy life style and medical therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>peers group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>group meetings and follow-up of un-balanced diabetic patients by trained peers (peers: balanced diabetic patients),which designed to promote adherence to healthy life style and medical therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SMS notifications</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>un-balanced diabetic patients receiving daily SMS with content,which designed to promote adherence to healthy life style and medical therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>un-balanced diabetic patients will get the basic and regular treatment for diabetic patients according to Clalit Health Services. In addition, the patients will have the same check-ups like all the patients in the experimental arms.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>medical team</intervention_name>
    <description>Lowering HbA1c by behavioral changes in meetings with the medical team.</description>
    <arm_group_label>medical team</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>peers group</intervention_name>
    <description>Lowering HbA1c by behavioral changes in meetings with the peers group.</description>
    <arm_group_label>peers group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMS notification</intervention_name>
    <description>Lowering HbA1c by behavioral changes in meetings with the SMS notification</description>
    <arm_group_label>SMS notifications</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. type 2 diabetes

          2. age 30-70

          3. Oral medication or insulin

          4. According to the HbA1c test result, 0.5% above the target for the patient's personal
             balance and below the 10%, the most recent, but in any event not more than six months
             prior to the study patient recruitment

          5. BMI&lt;35

          6. Patients speak and read Hebrew

          7. owners of a mobile phone that can receive text messages (SMS messages/ notifications)
             and have the ability to use the application (relevant for the SMS notification arm)

        Exclusion Criteria:

          1. Active malignant disease

          2. creatinine levels above 2

          3. Getting medicines that elevate sugar levels as steroids, chemotherapy

          4. Three months after Myocardial Infraction (myocardial ischemia), surgical intervention,
             cardiac event

          5. Patients who are planning major surgery

          6. Patients who are planning a residential zone change

          7. Patients with acute complications of diabetes under active treatment (such as limb
             amputation)

          8. Patients diagnosed with unbalanced mental disorders

          9. patients who can not sign the form on their own &quot;informed consent&quot;

         10. patients suffering from dementia

         11. Patients who are not mobile (dependent on the therapist)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margalit Goldfracht, prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director of the Department of promoting quality of family medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Margalit Goldfracht, prof.</last_name>
    <phone>+972-50-6263-214</phone>
    <email>MargalitGo@clalit.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Niky Liberman, D&quot;R</last_name>
    <phone>+972-50-6263050</phone>
    <email>nickyli@clalit.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clalit Health Institute</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>margalit Goldfracht, prof</last_name>
      <phone>+972-506263214</phone>
      <email>goldfrac@actcom.co.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2015</study_first_submitted>
  <study_first_submitted_qc>August 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2015</study_first_posted>
  <last_update_submitted>January 31, 2018</last_update_submitted>
  <last_update_submitted_qc>January 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>imbalanced diabetic patients</keyword>
  <keyword>HbA1c</keyword>
  <keyword>peers</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

